Lemalesomab Biosimilar - Research Grade

Human

NCA-90

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

Blue ice

NCA-90 (CEACAM-related nonspecific cross-reacting antigen) is expressed on granulocytes and has been explored as a marker in inflammation and myeloid imaging research. This human IgG1, kappa antibody is an unconjugated, non-therapeutic analog of lemalesomab that recognizes NCA-90 for functional studies. It is delivered in a low-endotoxin format compatible with in vivo experiments and produced in scalable milligram-to-gram batches built for bulk and high-throughput laboratories. For research use only (RUO), it can act as a binding reference and active reagent in granulocyte-targeting assays, antigen-detection panels, in vitro characterization, and preclinical inflammation or myeloid biology models.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks